Tyra Bioscience's market cap is currently ―. The company's EPS TTM is $-1.616; its P/E ratio is -9.07; Tyra Bioscience is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -22.83M	$ -21.15M	$ -13.27M	$ -11.88M	$ -15.04M
EBITDA	$ -22.73M	-	$ -13.19M	$ -11.80M	$ -14.96M
Net Income Common Stockholders	$ -22.83M	$ -21.15M	$ -13.27M	$ -11.88M	$ -12.88M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 203.47M	$ 215.65M	$ 232.41M	$ 241.70M	$ 251.20M
Total Assets	$ 225.86M	$ 238.36M	$ 250.01M	$ 255.06M	$ 266.17M
Total Debt	$ 6.50M	$ 6.11M	$ 6.07M	$ 2.59M	$ 2.62M
Net Debt	$ -196.97M	$ -209.54M	$ -226.34M	$ -239.11M	$ -248.58M
Total Liabilities	$ 21.59M	$ 16.19M	$ 11.44M	$ 6.26M	$ 266.18M
Stockholders Equity	$ 204.26M	$ 222.17M	$ 238.57M	$ 248.79M	$ 257.82M
Cash Flow	-
Free Cash Flow	$ -14.13M	-	$ -9.66M	$ -9.89M	$ -12.00M
Operating Cash Flow	$ -13.53M	$ -17.14M	$ -9.62M	$ -9.85M	$ -11.98M
Investing Cash Flow	$ -144.44M	$ -83.00K	$ -43.00K	$ -41.00K	$ -21.00K
Financing Cash Flow	$ 324.00K	$ 467.00K	$ 370.00K	$ 376.00K	$ 3.00K

Currency in USD

Tyra Bioscience Earnings and Revenue History

Income Statement >

Tyra Bioscience Debt to Assets

Balance Sheet >

Tyra Bioscience Cash Flow

Cash Flow >

Tyra Bioscience Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing